Three-year review of bacteriological profile and antibiogram of burn wound isolates in Van, Turkey

International Journal of Medical Sciences

Volumn 10, Issue 1, 2012, Pages 19-23

  Bayram, Yasemin ^a   Parlak, Mehmet ^a   Aypak, Cenk ^b   Bayram, Irfan ^c  

^a Van Training and Research Hospital   (Turkey)

^b Department of Family Medicine   (Turkey)

^c YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Antibiotic; Burns; Resistance; Wounds

Indexed keywords

AMIKACIN; AMPICILLIN; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; CLINDAMYCIN; COLISTIN; COTRIMOXAZOLE; DAPTOMYCIN; GENTAMICIN; IMIPENEM; LINEZOLID; MEROPENEM; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BURN; CONCENTRATION RESPONSE; DRUG EFFECT; ENTEROCOCCUS; ESCHERICHIA COLI; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; NONHUMAN; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; TURKEY (REPUBLIC);

ANTIBIOTIC; BURNS; RESISTANCE; WOUNDS.;

ADULT; AMIKACIN; BURNS; CARBAPENEMS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; INFECTION; MALE; RETROSPECTIVE STUDIES; TURKEY;

EID: 84871356439     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.4723     Document Type: Article

References (40)

1. Qader AR, Muhamad JA. Nosocomial infection in sulaimani burn hospital, Iraq. Ann Burns Fire Disasters. 2010; 23(4): 177-81.
2. Soares de Macedo JL, Santos JB. Nosocomial infections in a Brazilian Burn Unit. Burns. 2006; 32(4): 477-81.
3. Ahuja RB, Gupta A, Gur R. A prospective double-blinded comparative analysis of Framycetin and Silver Sulphadiazine as topical agents for burn. A pilot study. Burns. 2009; 35(5): 672-6.
4. Vindenes HA, Ulvested E, Bjerknes R. Concentrations of cytokines in plasma of patients with large burns: their relation to time after injury, burn size, inflammatory variables, infection and outcome. Eur J Surg. 1998; 164(9): 647-56.
5. Alexander M, Chaudry IH, Schwacha MG. Relationships between burn size, immunosuppresion, and macrophage hyperactivity in a murine model of thermal injury. Cell Immunol. 2002; 220(1): 63-9.
6. Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn wound infections. Clin Microbiol Rev. 2006; 19(2): 403-34.
7. Macedo JLS, Santos JB. Bacterial and fungal colonization of burn wounds. Mem Inst Oswaldo Cruz. 2005; 100(5): 535-39.
8. Taneja N, Emmanuel R, Chari PS, Sharma M. A p rospective s tudy o f hospital-acquired infections in burn patients at a tertiary care referral centre in North India. Burns. 2004; 30(7): 665-9.
9. Vindenal H, Bjerknes R. Microbial colonization of large wounds. Burns. 1995; 21(8): 575-9.
10. Singh D, Singh A, Sharma AK, Sodhi L. Burn mortality in Chandigarh zone: 25 years autopsy experience from a tertiary care hospital of India. Burns. 1998; 24(2): 150-6.
11. Sharma BR, Harish D, Singh VP, Bangar S. Septicemia as a cause of death in burns: an autopsy study. Burns. 2006; 32(5): 545-9.
12. Winn W, Allen S, Janda W, et al. Konemaǹs Color Atlas and Textbook of Diagnostic Microbiology. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2006.
13. Mayhall CG. The epidemiology of burn wound infections: then and now. Clin Infect Dis. 2003; 37(4): 543-50.
14. Rastegar Lari AR, Alaghehbandan R, Akhlaghi L. Burn wound infections and antimicrobial resistance in tehran, iran: an increasing problem. Ann Burns Fire Disasters. 2005; 18(2): 68-73.
15. Avni T, Levcovich A, Ad-El DD, Leibovici L, Paul M. Prophylactic antibiotics for burns patients: systematic review and meta-analysis. BMJ. 2010; 340: 241.
16. Pruitt BA Jr, McManus AT, Kim SH, Goodwin CW. Burn wound infections: current status. World J Surg. 1998; 22(2): 135-45.
17. Revathi G, Puri J, Jain BK. Bacteriology of burns. Burns. 1998; 24(4): 347-9.
18. Rastegar Lari A, Bahrami Honar H, Alaghehbandan R. Pseudomonas infections in Tohid Burn Center, Iran. Burns. 1998; 24(7): 637-41.
19. Wurtz R, Karajovic M, Dacumos E, Jovanovic B, Hanumadass M. Nosocomial infections in a burn intensive care unit. Burns. 1995; 21(3): 181-4.
20. Appelgren P, Björnhagen V, Bragderyd K, Jonsson CE, Ransjö U. A prospective study of infections in burn patients. Burns. 2002; 28(1): 39-46.
21. Santucci SG, Gobara S, Santos CR, Fontana C, Levin AS. Infections in a burn intensive care unit: experience of seven years. J Hosp Infect. 2003; 53(1): 6-13.
22. Chim H, Tan BH, Song C. Five-year review of infections in a burn intensive care unit: High incidence of Acinetobacter baumannii in a tropical climate. Burns. 2007; 33(8): 1008-14.
23. Siau H, Yuen KY, Ho PL, Wong SSY, Woo PCY. Acinetobacter bacteremia in Hong Kong: prospective study and review. Clin Infect Dis. 1999; 28(1): 26-30.
24. Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis. 2006; 42(5): 692-9.
25. McDonald LC, Banerjee SN, Jarvis WR. Seasonal variation in Acinetobacter infection: 1987-1996. Clin Infect Dis. 1999; 29(5): 1133-7.
26. Lari AR, Alaghehbandan R. Nosocomial infections in an Iranian burn care center. Burns. 2000; 26(8): 737-40.
27. Song W, Lee KM, Kang HJ, Shin DH, Kim DK. Microbiological aspects of predominant bacteria isolated from the burn patients in Korea. Burns. 2001; 27(2): 136-9.
28. Gupta A K, U ppal S, Garg R, Gupta A, Pal R. A clinico-epidemiologic study of 892 patients with burn injuries at a tertiary care hospital in Punjab, India. J Emerg Trauma Shock. 2011; 4(1): 7-11.
29. Rezaei E, Safari H, Naderinasab M, Aliakbarian H. Common pathogens in burn wound and changes in their drug sensitivity. Burns. 2011; 37(5): 805-7.
30. Sharma BR. Infection in patients with severe burns; cause and prevention thereof. Infect Dis Clin North Am. 2007; 21(3): 745-59.
31. Hodle AE, Richter KP, Thompson RM. Infection control practices in U.S. burn units. Mol Biol Rep. 2006; 27(2): 142-51.
32. Ozumba UC, Jiburum BC. Bacteriology of burn wounds in Enugu, Nigeria. Burns. 2000; 26(2): 178-80.
33. Huan JN, Tang JJ. Drug-resistance Acinetobacter baumannii infection in burn patients: current situation and countermeasure. Zhonghua Shao Shang Za Zhi. 2011; 27(2): 84-7.
34. Jones RN, Pfaller MA, Doern GV, Erwin ME, Hollis RJ. Antimicrobial activity and spectrum investigation of eight broad-spectrum b-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. The Cefepime Study Group. Diagn Microbiol Infect Dis. 1998; 30(3): 215-28.
35. Stratchounski LS, Kozlov RS, Rechedko GK, Stetsiouk OU, Chavrikova EP. Antimicrobial resistance patterns among aerobic gram-negative bacilli isolated from patients in intensive care unit: results of multicenter study in Russia. The Russian NPRS Study Group. Clin Microbiol Infect. 1998; 4: 497-507.
36. Hanberger H, Garcia-Rodriguez JA, Gobernado M, Goossens H, Nilsson LE, Struelens MJ. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. J Am Med Assoc. 1999; 281(1): 67-71.
37. Lesseva MI, Hadjiiski OG. Staphylococcal infections in the Sofia Burn Centre, Bulgaria. Burns. 1996; 22(4): 279-82.
38. Spencer RC, Bauernfeind A, Garcia-Rodriguez J, Jarlier V, Pfaller M, Turnidge J et al. Surveillance of the current resistance of nosocomial pathogens to antimicrobials. Clin Microbiol Infect 1997;3:21-35.
39. Giske CG, Monnet DL, Cars O, Carmeli Y. ReAct-Action on Antibiotic Resistance; Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother. 2008; 52(3): 813-21.
40. Guggenheim M, Zbinden R, Handschin AE, Gohritz A, Altintas MA, Giovanoli P. Changes in bacterial isolates from burn wounds and their antibiograms: a 20-year study (1986-2005). Burns. 2009; 35(4): 553-60.